Walleye Trading
EBS icon

Walleye Trading’s Emergent Biosolutions EBS Stock Holding History

Walleye Trading’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,000
Closed -$44.7K – 4475
2025
Q2 		$44.7K Buy
+7,000
New +$40.1K ﹤0.01% 3838
2023
Q4 		– Sell
-8,800
Closed -$29.9K – 5159
2023
Q3 		$29.9K Sell
8,800
-31,800
-78% -$176K ﹤0.01% 4319
2023
Q2 		$298K Buy
+40,600
New +$376K ﹤0.01% 3152
2022
Q4 		– Sell
-14,100
Closed -$296K – 5065
2022
Q3 		$296K Buy
+14,100
New +$392K ﹤0.01% 3383
2015
Q2 		– Sell
-3,500
Closed -$101K – 4898
2015
Q1 		$101K Buy
+3,500
New +$100K ﹤0.01% 2657

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OHA
Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return